GE HealthCareGEHC
About: GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%).
Employees: 51,000
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
93% more first-time investments, than exits
New positions opened: 156 | Existing positions closed: 81
25% more funds holding in top 10
Funds holding in top 10: 8 [Q2] → 10 (+2) [Q3]
19% more capital invested
Capital invested by funds: $29.6B [Q2] → $35.2B (+$5.65B) [Q3]
14% more repeat investments, than reductions
Existing positions increased: 462 | Existing positions reduced: 404
12% more call options, than puts
Call options by funds: $579M | Put options by funds: $518M
5% more funds holding
Funds holding: 1,190 [Q2] → 1,246 (+56) [Q3]
0.77% less ownership
Funds ownership: 83.22% [Q2] → 82.45% (-0.77%) [Q3]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Jefferies Matthew Taylor 50% 1-year accuracy 2 / 4 met price target | 17%upside $103 | Buy Upgraded | 8 Jan 2025 |
Financial journalist opinion
Based on 17 articles about GEHC published over the past 30 days
